Copy number variations associated with fetal congenital kidney malformations. 2020

Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
Department of the Prenatal Diagnosis Center, Fujian Provincial Maternity and Children's Hospital, affiliated hospital of Fujian Medical University, Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fuzhou, China.

BACKGROUND Congenital anomalies of the kidney and urinary tract (CAKUT) constitute 20-30% of all congenital malformations. Within the CAKUT phenotypic spectrum, renal hypodysplasia (RHD) is particularly severe. This study aimed to evaluate the applicability of single-nucleotide polymorphism (SNP) array test in prenatal diagnosis of RHD for improving prenatal genetic counseling and to search for evidence of a possible causative role of copy-number variations (CNVs) in RHD. RESULTS We performed a systematic survey of CNV burden in 120 fetuses with RHD: 103 cases were isolated RHD and 17 were non-isolated RHD. Single-nucleotide polymorphism (SNP) array test was performed using the Affymetrix CytoScan HD platform. All annotated CNVs were validated by fluorescence in situ hybridization. We identified abnormal CNVs in 15 (12.5%) cases of RHD; of these CNVs, 11 were pathogenic and 4 were variants of uncertain significance. The detection rate of abnormal CNVs in non-isolated RHD was higher (29.4%, 5/17) than that in isolated RHD (9.7%, 10/103) (P = 0.060). Parents are more inclined to terminate the pregnancy if the fetuses have pathogenic results of the SNP-array test. CONCLUSIONS The variable phenotypes that abnormal CNVs may cause indicate the genetic counseling is needed for RHD cases.

UI MeSH Term Description Entries

Related Publications

Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
June 2018, Genetics in medicine : official journal of the American College of Medical Genetics,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
January 2017, Current molecular medicine,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
December 2012, American journal of human genetics,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
April 2018, Current opinion in obstetrics & gynecology,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
October 2008, Nature,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
February 2016, Prenatal diagnosis,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
March 2015, American journal of medical genetics. Part A,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
August 2008, Pharmacogenomics,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
January 2020, Cytogenetic and genome research,
Meiying Cai, and Na Lin, and Linjuan Su, and Xiaoqing Wu, and Xiaorui Xie, and Ying Li, and Xuemei Chen, and Yuan Lin, and Hailong Huang, and Liangpu Xu
March 2015, European journal of medical genetics,
Copied contents to your clipboard!